Global Trial to Assess Chloroquine Against COVID-19 in Health Workers

May 19, 2020

(UPI) – More than 50,000 healthcare workers worldwide will be enrolled in a clinical trial to assess chloroquine’s potential in protecting against COVID-19, researchers at the Washington University of St. Louis School of Medicine announced Monday. The U.S. arm of the study, which will begin enrolling participants later this month, is being led by the school. Results are expected in early 2021, researchers said.